Centrifugation for Viral Vector Manufacturing

Centrifugation is a cornerstone in the intricate process of manufacturing viral vectors, serving as a vital instrument for their purification in gene therapy and vaccine development. It begins with viral packaging of the Adeno-associated virus (AAV), adenovirus, or other popular vectors using specialized cell-lines. In the case of AAV or adenovirus, variations of human embryonic kidney cells 293 containing viral machinery components are used. Once these cells are induced with a plasmid transfection providing helper/replication or accessory genes, they begin to package or produce viral particles. After transduction of viral packaging genes, the cells containing viral particles are collected via centrifugation to form a cell pellet for downstream processing. A clarified sample is prepared to extract the capsids or viral particles using gradient ultracentrifugation with either iodixanol, cesium chloride, or other popular gradient solutions. After capsids or viral particles are collected post ultracentrifugation, downstream processing can include the use of viral concentrators with centrifuges to prepare the final product for purposes of resuspending the viral capsids or particles in a desired titer or concentration, and in replacement of buffers suitable for in vivo applications.

Centrifuge Techniques used in Viral Vector Production

The types of centrifugation methods can be stratified into two categories. The first being differential centrifugation which is based on sample size separation using a series of runs at different speeds and durations. This method allows for the isolation of cells, or even specific organelles. The second category is density gradient centrifugation. This is achieved by using different types of media to separate cells, organelles, or particles. Density gradient centrifugation can be further subdivided into two types. The first type is rate-zonal centrifugation, which is achieved by creating several layers with the more dense layer at the bottom in a step-wise decelerating fashion to the least dense layer at the top. This results in the separation of particles by mass and size, and is commonly used for separation of cellular organelles, proteins, and antibodies. The second method within density centrifugation is isopycnic centrifugation, which separates particles based on density alone, and is the most common application in the isolation of nucleic acids and viral particles.

Multiple centrifugation approaches are used to address the specific needs of viral vector production. Key strategies include careful differential centrifugation while collecting the viral packaging cells for viral particle or capsid extraction, and isopycnic centrifugation, using common gradient solutions like iodixanol or cesium chloride in the creation of purified viral layers for extraction. These two approaches play critical roles in ensuring the purity and efficacy of viral vectors in gene therapy applications.

Considerations during density ultracentrifugation

Using ultracentrifugation for separation of viral particles with cesium chloride or iodixanol requires a series of considerations at each step for an optimum yield. It begins with the isolation of the viral particles or capsids with optimized freeze thaw cycles, and careful selection of buffers during the fixation toproduce the clarified viral lysate.

Additional operator needs during the ultracentrifugation process include the following:

• Laying the density gradients carefully without disrupting previous layers while preparing for the ultracentrifugation
• Pre-cooling the ultracentrifuge to 4^°C prior to placing samples into the ultracentrifuge
• Rating the rotor is for density of separation method used, particularly in the case of cesium chloride
• Programing the ultracentrifuge to accelerate and decelerate the samples at the lowest setting to ensure the viral layers are not disrupted or compromised
• Using a high-quality ultracentrifuge with electronic components for managing power surges without disruption of velocity during the ultracentrifugation run